Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENFN | Class A Common Stock | Award | $0 | +5.65 K | +3.59% | $0.00 | 163 K | Jan 5, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENFN | Stock Option (Right to Buy) | Award | $0 | +9.34 K | $0.00 | 9.34 K | Jan 5, 2023 | Class A Common Stock | 9.34 K | $11.06 | Direct | F2 |
Id | Content |
---|---|
F1 | Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 1,884, 1,884, and 1,883 RSUs will vest on January 5, 2024, January 5, 2025, and January 5, 2026, respectively. |
F2 | These options were granted under the Plan and shall become exercisable as follows: 3,115, 3,114, and 3,114 on January 5, 2024, January 5, 2025, and January 5, 2026, respectively. |
Exhibit 24 - Power of Attorney